Creative Medical Technology Holdings, Inc. - Common Stock (NQ:CELZ)

0.9200 -0.0264 (-2.79%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Creative Medical Technology Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 10, 2025

Via Benzinga

Top movers in Friday's pre-market session ↗

March 28, 2025

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 23, 2024

Via Benzinga

What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?

August 24, 2023

Via ACCESSWIRE

Are Pharma Stocks Harmful To Your Financial Health ? ↗

October 09, 2024

It seems time for the Securities and Exchange Commission to oversee stock advertising and consider a ban, or at least a danger warning label.

Via Talk Markets

CELZ Stock Earnings: Creative Medical Tech Misses EPS for Q2 2024 ↗

August 12, 2024

CELZ stock results show that Creative Medical Tech missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

CELZ Stock Earnings: Creative Medical Tech Beats EPS for Q1 2024 ↗

May 13, 2024

CELZ stock results show that Creative Medical Tech beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Creative Medical Technology Holdings Provides Corporate Update

March 27, 2024

From Creative Medical Technology Holdings, Inc.

Via Business Wire

Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA

March 08, 2024

Via AB Newswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 07, 2024

Via Benzinga

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 07, 2024

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Via Benzinga

Why Is Diabetes Focused Creative Medical Stock Surging On Thursday? ↗

March 07, 2024

FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program, targets abnormal glucose tolerance to prevent Type 1 diabetes.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 07, 2024

Via Benzinga

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access

March 07, 2024

From Creative Medical Technology Holdings, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 06, 2024

Via Benzinga

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

March 06, 2024

From Creative Medical Technology Holdings, Inc.

Via Business Wire

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

December 20, 2023

Via ACCESSWIRE

Creative Medical Technology Holdings (NASDAQ: CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem™ For Addressing Chronic Lower Back Pain ↗

December 19, 2023

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 31, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 31, 2023

It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 09, 2023

It's time to start off the week with a breakdown of the biggest pre-market stock movers that investors need to know about for Monday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 13, 2023

Via Benzinga

Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

September 13, 2023

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 13, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!

Via InvestorPlace

What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth? ↗

August 23, 2023

Biotechnology company Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) seems to be witnessing success in the allogeneic cell therapy market.

Via Benzinga

Why EVgo Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

August 03, 2023

Gainers

Via Benzinga

Why Rover Group Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

August 02, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares surged 52.1% to $0.1049 in pre-market trading.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.